# FDA Warning Letter: Eurosirel S.P.A
> 2024-11-26 · Center for Drug Evaluation and Research (CDER) · `9e943fe928b66f0d`
## Letter
- **Company:** Eurosirel S.P.A
- **Posted Date:** 2024-11-26
- **Letter Issue Date:** 2024-11-20
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*